Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium fortuitum and Mycobacterium chelonei to augmentin.

× No keyword cloud information.

5 in total

1. In vitro susceptibility of mycobacterium fortuitum and mycobacterium chelonei to cefoxitin.

Authors: M Casal; F Rodríguez
Journal: Tubercle Date: 1982-06

2. Simple, new test for rapid differentiation of the Mycobacterium fortuitum complex.

Authors: M J Casal; F C Rodriguez
Journal: J Clin Microbiol Date: 1981-05 Impact factor: 5.948

3. In vitro susceptibility of Mycobacterium fortuitum and M. chelonei to sisomicin, gentamicin and tobramycin.

Authors: M J Casal; F C Rodriguez
Journal: Ann Microbiol (Paris) Date: 1983 Nov-Dec

4. In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis.

Authors: M H Cynamon; G S Palmer
Journal: Antimicrob Agents Chemother Date: 1983-09 Impact factor: 5.191

5. In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins.

Authors: M H Cynamon; G S Palmer
Journal: Antimicrob Agents Chemother Date: 1982-12 Impact factor: 5.191

5 in total

12 in total

1. Altered permeability and beta-lactam resistance in a mutant of Mycobacterium smegmatis.

Authors: S Mukhopadhyay; P Chakrabarti
Journal: Antimicrob Agents Chemother Date: 1997-08 Impact factor: 5.191

2. Cloning and sequence analysis of a class A beta-lactamase from Mycobacterium tuberculosis H37Ra.

Authors: C J Hackbarth; I Unsal; H F Chambers
Journal: Antimicrob Agents Chemother Date: 1997-05 Impact factor: 5.191

3. Meropenem-clavulanic acid has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.

Authors: L Davies Forsman; C G Giske; J Bruchfeld; T Schön; P Juréen; K Ängeby
Journal: Antimicrob Agents Chemother Date: 2015-03-30 Impact factor: 5.191

4. Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid.

Authors: R J Wallace; B A Brown; G O Onyi
Journal: Antimicrob Agents Chemother Date: 1991-04 Impact factor: 5.191

Review 5. Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors: P A Todd; P Benfield
Journal: Drugs Date: 1990-02 Impact factor: 9.546

6. Contribution of beta-lactamases to beta-lactam susceptibilities of susceptible and multidrug-resistant Mycobacterium tuberculosis clinical isolates.

Authors: C Segura; M Salvadó; I Collado; J Chaves; A Coira
Journal: Antimicrob Agents Chemother Date: 1998-06 Impact factor: 5.191

Review 7. Drug treatment of tuberculosis--1992.

Authors: P T Davidson; H Q Le
Journal: Drugs Date: 1992-05 Impact factor: 9.546

8. Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?

Authors: H F Chambers; D Moreau; D Yajko; C Miick; C Wagner; C Hackbarth; S Kocagöz; E Rosenberg; W K Hadley; H Nikaido
Journal: Antimicrob Agents Chemother Date: 1995-12 Impact factor: 5.191

9. Can inhibitor-resistant substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC lead to clavulanate resistance?: a biochemical rationale for the use of β-lactam-β-lactamase inhibitor combinations.

Authors: Sebastian G Kurz; Kerstin A Wolff; Saugata Hazra; Christopher R Bethel; Andrea M Hujer; Kerri M Smith; Yan Xu; Lee W Tremblay; John S Blanchard; Liem Nguyen; Robert A Bonomo
Journal: Antimicrob Agents Chemother Date: 2013-09-23 Impact factor: 5.191

Review 10. Have we realized the full potential of β-lactams for treating drug-resistant TB?

Authors: Elizabeth Story-Roller; Gyanu Lamichhane
Journal: IUBMB Life Date: 2018-06-22 Impact factor: 3.885